Product Details for NDA 009435
NESACAINE (CHLOROPROCAINE HYDROCHLORIDE)
1%
Marketing Status: Prescription
2%
Marketing Status: Prescription
2%
Marketing Status: Prescription
3%
Marketing Status: Prescription
2%
Marketing Status: Discontinued
3%
Marketing Status: Discontinued
1%
Marketing Status: Prescription
Active Ingredient: CHLOROPROCAINE HYDROCHLORIDE
Proprietary Name: NESACAINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009435
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
NESACAINE (CHLOROPROCAINE HYDROCHLORIDE)
Proprietary Name: NESACAINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009435
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
2%
Marketing Status: Prescription
Active Ingredient: CHLOROPROCAINE HYDROCHLORIDE
Proprietary Name: NESACAINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N009435
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
NESACAINE-MPF (CHLOROPROCAINE HYDROCHLORIDE)
Proprietary Name: NESACAINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N009435
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
2%
Marketing Status: Prescription
Active Ingredient: CHLOROPROCAINE HYDROCHLORIDE
Proprietary Name: NESACAINE-MPF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N009435
Product Number: 006
Approval Date: May 2, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
NESACAINE-MPF (CHLOROPROCAINE HYDROCHLORIDE)
Proprietary Name: NESACAINE-MPF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N009435
Product Number: 006
Approval Date: May 2, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
3%
Marketing Status: Prescription
Active Ingredient: CHLOROPROCAINE HYDROCHLORIDE
Proprietary Name: NESACAINE-MPF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N009435
Product Number: 007
Approval Date: May 2, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
NESACAINE-MPF (CHLOROPROCAINE HYDROCHLORIDE)
Proprietary Name: NESACAINE-MPF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N009435
Product Number: 007
Approval Date: May 2, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
2%
Marketing Status: Discontinued
Active Ingredient: CHLOROPROCAINE HYDROCHLORIDE
Proprietary Name: NESACAINE-MPF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N009435
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
NESACAINE-MPF (CHLOROPROCAINE HYDROCHLORIDE)
Proprietary Name: NESACAINE-MPF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N009435
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
3%
Marketing Status: Discontinued
Active Ingredient: CHLOROPROCAINE HYDROCHLORIDE
Proprietary Name: NESACAINE-MPF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N009435
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: NESACAINE-MPF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N009435
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information